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Abstract
Background: Interpreting the results of high-throughput experiments, such as those obtained
from DNA-microarrays, is an often time-consuming task due to the high number of data-points that
need to be analyzed in parallel. It is usually a matter of extensive testing and unknown beforehand,
which of the possible approaches for the functional analysis will be the most informative
Results: To address this problem, we have developed the Flexible Annotation and Correlation Tool
(FACT). FACT allows for detection of important patterns in large data sets by simplifying the
integration of heterogeneous data sources and the subsequent application of different algorithms
for statistical evaluation or visualization of the annotated data. The system is constantly extended
to include additional annotation data and comparison methods.
Conclusion: FACT serves as a highly flexible framework for the explorative analysis of large
genomic and proteomic result sets. The program can be used online; open source code and
supplementary information are available at http://www.factweb.de.
Background
A variety of algorithms and programs have been intro-
duced to accomplish the processing of raw data as well as
the statistical analysis of data from high-throughput
experiments. But besides the mathematical complexity
that needs to be handled, there is a biological complexity
inherent to the data sets, too. Current means to analyze
large-scale data sets usually target very specific questions
and often fail to provide solutions that can be adapted to
different types of data. Nevertheless, common and gener-
alized questions for the interpretation of such data can be
established as follows: i) What information is known
about the analyzed features (clones, genes, e.g.)? ii) Are
there correlations between the experimental outcomes
and the additional information (shared pathways, etc.)?
iii) Is the outcome comparable with results of other exper-
iments (genomic or gene expression data sets, publica-
tions, etc.)?
The program Flexible Annotation and Correlation Tool
(FACT) was developed to address these questions by inte-
grating data sources, tools and algorithms in a single open
framework. First, FACT allows merging information from
various data sources into one comprehensive annotation
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analysis tools to inspect and correlate this heterogeneous
information. The functionality of FACT can be extended
through the inclusion of new data sources, algorithms and
programs by defining additional modules from a proto-
type. This flexibility is achieved by a strong level of
abstraction from the actual data, by the design of the
underlying database and by the modular architecture of
the software itself. The task to identify relevant biological
interconnections reflected by the experimental results
(e.g. participation of the analyzed genes in shared path-
ways) is what we are targeting with the software intro-
duced here.
Implementation
Integration of data sources
The integration of bio-molecular data from diverse
sources such as public databases or clinical parameters
(annotation) is a key challenge in the process of the analy-
sis of high-throughput experiments. While the interpreta-
tion of the outcome of a standard experiment used to
depend on the knowledge of one human expert from the
field, today's screening tools produce data quantities not
manageable by human inspection. After receiving a list of
differentially regulated genes from a microarray gene
expression experiment comprising several hundreds or
thousands of entries, it is not efficient to start the interpre-
tation of these results by manually searching through
publications. As a first step, broad biological themes
should be identified and followed into a more detailed
inspection.
Using network technologies, the availability of data
sources is no more the limiting factor, but if accomplished
manually, the obstacles for their integration are numer-
ous. Often data are made available in different formats
(HTML pages, flat files, direct database access) and very
heterogeneous layouts. In addition the nomenclature (e.g.
gene names) as well as the relationship of different sys-
tems to each other are often inconsistent and require
many manual selection and modification steps. At the
same time, as much knowledge as possible should be inte-
grated about the data features analyzed, since interesting
unknown pathways and interconnections might be hid-
den behind biological complexity.
As the first aspect, FACT accomplishes the task of integrat-
ing heterogeneous information sources by abstraction
from the specific data types to one basic concept. (figure
1, lower part). The smallest entities are data features, which
are single items of information, either a name/value pair
or additional textual description thereof. This could be a
list of ids of clones with their relative expression as meas-
ured on a cDNA microarray. They are grouped into data
sets, combining data features relating to the same experi-
ment or a group of annotation terms for a certain set. In
our example the clone/ratio pairs measured in one
hybridization would be stored as one data set. The data
sets originate from specific data sources, defining distinct
types of experiments or annotation sources. One data
source would be "cDNA microarray measurements with
textual clone ids and numerical results". This architecture
follows the idea, that the primary data must be repre-
sented at a sufficient level of abstraction to make the data
independent of the source technology [1]. The concept
applies to experimental as well as to annotation data.
Meta-data about the different data sources is stored in
dedicated tables of the underlying database, describing
the source with date and type of data.
Differences in nomenclature and the problem of relating
one type of experiment to an other, as the second obstacle
for data integration, has been addressed for gene and pro-
tein centered research by the development of the GeneOn-
tology system (GO) [2]. This hierarchical framework of a
directed acyclic graph of annotations for gene attributes
has become a de facto standard, which can be employed in
the functional analysis of experiments. Similar projects
have been initiated for example to organize the classifica-
tion of molecular interactions in pathways and molecular
complexes (Genome Knowledgebase / Reactome [3]).
Using these resources FACT is able to compare experimen-
tal results from technically distant applications.
However, most experiments differ in focus and design and
usually no standard solution for their interpretation can
be applied. The third aspect for an integrating approach
therefore is high flexibility concerning the application of
diverse analysis methods that have already been devel-
oped for the interpretation of results or might be used in
future.
Architecture
FACT consists of a MySQL database, a core library (as an
Application Programming Interface, API) and various mod-
ules written in the language Perl. We also created an inter-
face for the web-based usage of all functions of FACT [4].
The database reflects the transformation of heterogeneous
data into a generalized format, storing information in
DateSet and DataFeature tables (figure 2). The core soft-
ware framework supplies the basic functionality for data
access in an object-oriented fashion and for adding and
operating modules. These modules are adaptors and can
be classified into three categories (figure 3):
I. Data loading
Different types of experimental data can be loaded using
dedicated parser functions. This can be a simple functions
to read tab-delimited data defined e.g. as a gene list with
associated expression values. It can also be a morePage 2 of 12
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parative genomic hybridizations (CGH), a method that is
employed to monitor copy numbers changes of all
regions of a genome simultaneously on chromosome
spreads. The individual modules read the specific file for-
mat, perform transformations to the generalized format
(i.e. convert them into data features) and use core library
functions to store the data.
II. Annotation
Varying data sources can be utilized for the annotation of
experimental data sets by different data-access functions
(e.g. GO terms for gene names). Modules achieve this for
instance through access to an online database or to a local
copy of such database. Data of interest are then gathered
and stored.
III. Analysis
Different functions can be used to inspect the annotated
information and highlight underlying patterns (e.g. over-
represented GO-terms). The modules typically produce
textual and graphical output to draw the researcher's
attention to the most promising features of his data.
Currently available functions of FACT are described
below. Further flexibility is achieved by the concept of
experimental and annotational data being reduced to the
basic model of one data set with several data features, as
described above.
All these modules use the FACT API. It offers a defined
interface for the effortless extension to new sources and
functions. Prototype modules for each category imple-
menting this API are supplied. For the integration of
annotation sources, available data can either be trans-
ferred to the local system (data warehousing) or linked to
the original source (database federation); the FACT sys-
tem allows both options to be used by the module func-
tions. Currently remote databases are accessed by the
EnsEMBL, BBID and Reactome modules; the CpG and
CGAP functions use locally stored information (see
below). The update of the local data is accomplished
Layered architecture of the FACT frameworkFigure 1
Layered architecture of the FACT framework. The database reflects the abstraction of any experimental or annotation 
data to DataSets with DataFeatures, originating from a specific DataSource for which DataTypes and Parameters have been 
defined. The core library (API) supplies all functionality for accessing the database and for the operation of diverse modules, 
which are adaptors for specific DataSources or functions. The web interface or other applications are using FACT API 
functions.Page 3 of 12
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function in the separate modules.
Finally, as there is an active development of software for
the annotation and analysis of gene expression data in the
language R (Bioconductor project [5]), and the handling
of large data matrices is accomplished faster in R, we used
the Perl/R interface RSPerl [6] in different modules to
encapsulate analysis functions written in R. Other mod-
ules employ the functionality from the BioPerl [7] and
Ensembl Perl API [8].
Available functionality
A variety of modules for the handling of different data
sources (table 1) as well as for the application of basic
data analysis and display functions (table 2) were devel-
oped. Most of the current functionality is focused on han-
dling human and murine gene annotation information.
Additional functionality can be added in a "plug-and-
play" fashion, since new modules can be loaded dynami-
cally into FACT.
To read in experimental results, a simple list (with terms
or term-value pairs) or table can be used, or more
specialized parser functions can be employed to read and
decipher the notations of different types of results. One
parser (2_Colums) reads tab-, or semicolon-separated lists
and stores the data as terms of the data type that is passed
as a parameter (e.g. gene symbol or clone id) and the
respective value. Another function (LongList) expects
terms only (list of genes that are to be annotated) or
Affymetrix probe ids (AffyCelFile). The parser for CGH
results translates ISCN notations of cytogenetic alterations
[9] into the distinct chromosomal bands that are affected
FACT database schemaigure 2
FACT database schema. The database schema reflects the generalized handling of heterogeneous data. At the definition 
layer the data sources are defined as experimental, annotational or analysis sources. Also the types of data that they use are 
specified here. These types are linked to the individual sources which are defined in the data source layer. Parameters that the 
functions handling the sources can take are stored as well. The actual data – experimental as well as annotational – are saved as 
data set and data features in the data set layer.Page 4 of 12
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alteration -1 (loss of genomic material), +1 (gain), or +2
(high level amplification).
Data sources that can then be used for annotating these
experimental results contain among others EnsEMBL data-
bases [8], with functions providing numerous gene anno-
tations on the human and murine genome (gene name,
accession numbers, genomic localization, GO terms and
other ids). The annotation data is fetched by using the
EnsEMBL API or direct sql queries. Chromosomal loca-
tions expressed as cytogenetic bands can be translated in
megabasepair positions. This can permit the direct com-
parison of results from genomic and expression experi-
ments. Most common identifiers (IMAGE IDs, DDBJ/
EMBL/GenBank accession numbers, international clone
names, MGD (Mouse-Genome Database) IDs or Probe-
IDs as used on expression microarrays in the Affymetrix
system) are recognized and used by the different annota-
tion modules. Additionally, homologous genes, sequence
features, InterPro protein domains, CpG content and
PubMed references can be acquired. The euGenes database
[10] modules delivers an additional set of broad annota-
tions (Gene Symbol and Name, GDB ID, OMIM ID,
Genomic Localization, GO terms, etc.). The BBID module
searches for representations of affected pathways in the
Biological Biochemical Image Database [11]. We store links
to the images which sometimes allow the clarification of
interactions better than textual description alone. Addi-
tionally data is used from STRING [12] and Reactome [3]
to point out protein interactions and involvement in
molecular complexes.
Annotation steps can be concatenated, allowing deriving
from specific (e.g. Affymetrix Probe-IDs) to more general
terms (e.g. gene symbols). This broad annotation that is
facilitated by FACT is crucial for the researcher to acquire
a complete picture of his data. The user can export the
combined lists of annotated data in HTML, XML or text
format. If desired the system can send them by email.
Modules to correlate these annotated datasets with each
other have been developed for FACT, incorporating exist-
ing algorithms or presenting new approaches (table 2).
For example, a counting procedure (SimpleCount) reports
the number of occurrences of each annotation term. The
module is independent of the type of data, one or more
data sets can be added up and a threshold for reporting
Outline of the flow of informationFigur 3
Outline of the flow of information. Modular DataSource-Adapters accomplish data access and data transformation from 
heterogeneous sources, making FACT a flexible framework.Page 5 of 12
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chart and in a table format, directing the researcher's
attention to distinct characteristics (figure 4). A more spe-
cific approach to interpret list of genes lies in the explicit
usage of GO terms. As originally introduced by Khatri et
al. in the program OntoExpress [13] there are different
methods and implementation to search for those parts of
the GO tree that appear more often in the gene list ana-
lyzed than by chance alone. For FACT we used an imple-
mentation from the GeneMerge program [14] and the
GO::TermFinder perl module [15]. Occurrences of terms
in a gene list are normalized against a background, which
might contain the annotations of all terms spotted on a
chip or the entire genome, by using the hypergeometric
tail probability (with Bonferroni correction if desired,
example: figure 5). In our implementation, the function
can be applied on GO data as well as on any other kind of
annotation to detect overrepresented terms. Alternatively
the Fisher's exact test can be used for this purpose. We
included part of this method taken from the EASE pro-
gram [16] in a FACT function. We also developed a com-
bined algorithm, which calculates a K-Means similarity
matrix based on the experimental values and reports on
significant terms with the Fisher's exact test within the
identified groups afterwards (goCluster, G. Wrobel, availa-
ble at http://www.bioconductor.org). Another analysis
module dedicated to the comparison of genomic and
expression data runs pairs of two-sided T-Tests on the
groups of over- and under-expressed genes against the
groups of enhanced/amplified and deleted genomic
regions. This allows detecting a correlation between an
altered genomic locus and the corresponding expression
pattern. FACT can also represent experimental values or
frequency counts in the genomic context which can be
helpful for the identification and representation of locali-
zation effects in the genome. This is achieved by reading
in the genomic locations of data sets and generating bar
chart images on top of prepared chromosome ideograms
Table 1: Data Types and Sources accessible by current annotation modules.
Data source, access method Data provider, data location Type of annotation used by FACT
Ensembl, Perl API access to local or remote 
database
European Bioinformatics Institute and 
Wellcome Trust Sanger Institute (GB) [8], 
http://www.ensembl.org
Ensembl ID, Gene Symbol, Gene Name, 
Chromosomal Location, Homologues Genes, 
Interpro Domains, RefSeq Accession Number, 
Affymetrix ID
euGenes, local database University of Indiana (USA) [10], ftp://
iubio.bio.indiana.edu/eugenes/
euGene ID, Gene Symbol, Gene Name, GDB 
ID, OMIM ID, Genomic Localization, 
GeneOntology Terms, Protein Accession 
Numbers
Image Consortium, local database Lawrence Livermore National Laboratory 
(USA) [28], ftp://image.llnl.gov/image/imagene/
Clone Image ID
Biological Biochemical Image Database, HTTP 
parser and HTTP request
National Institute of Aging, NIH (USA) [11], 
http://bbid.grc.nia.nih.gov/cgi-bin/
pathwaysearch.pl
Pathway Name and Image-link
GeneOntology, local database GeneOntology Consortium [2], http://
www.geneontology.org/
GO.current.annotations.shtml
ID and Name of GO-Term (Biological Process, 
Molecular Function, Cellular Localization)
Cancer Genome Anatomy Project, local database National Cancer Institute, NIH (USA) [29], ftp:/
/ftp1.nci.nih.gov/pub/CGAP
Biocarta name, Biocarta short name, KEGG 
Pathway Name, KEGG Pathway ID, PFAM ID
LocusLink / EntrezGene, local database NCBI/NIH (USA) [30], ftp://ftp.ncbi.nih.gov/
refseq/LocusLink / ftp://ftp.ncbi.nih.gov/gene
A. LocusLink ID, Gene Symbol, Gene Name, 
Genomic Localization, GeneOntology Terms, 
OMIM ID B. Key references (PubMed links)
Mouse Genome Database, local database Jackson Laboratory (USA) [31], ftp://
ftp.informatics.jax.org
MGI ID / Gene Symbol
Internal CloneBase, local database Deutsches Krebsforschungs zentrum, Div. 
Molecular Genetics (D)
General Information on available Clones




Calculated relative CpG content of genomic 
region
STRING, local database EMBL (D) [12], http://string.embl.de (medium 
or better confidence)
Protein interaction data (computed and 
imported from other databases)
Affymetrix CEL files Affymetrix Inc. / FACT, http://
www.affymetrix.com
Use of Affymetrix probe IDs
Reactome, local database and HTTP request European Bioinformatics Institute (GB) [3], 
http://www.reactome.org/download
Pathway informationPage 6 of 12
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ture mining tool which uses the Bio::Biblio perl functions
to find citations that are shared by two or more gene (Fig-
ure 5). Example output files are also available at [4].
Application of the program
The Flexible Annotation and Correlation Tool has proven
especially helpful with the interpretation of results from
genomic and expression microarray experiments, but
most functions can be applied to a broad variety of exper-
imental data.
We demonstrate the benefits of FACT for the functional
interpretation of the results from a comprehensive analy-
sis of gene expression patterns in the development of non-
melanoma skin-cancer conducted within our group [L.
Hummerich et al.: Identification of novel tumor-associated
genes in the process of squamous cell cancer development; sub-
mitted]. Using two different sets of microarrays with
15.000 and 20.000 cDNA fragments respectively, the
chemically induced multi-step development of squamous
cell carcinoma was monitored. We used the dorsal skin of
mice as a well-studied system for the development of epi-
thelial cancer [18] with the carcinogen 7,12-dimethyl-
benz-[a]-anthracene and the tumor promoter 12-O-
tetradecanoylphorbol-13-acetate as inducing agents.
Expression values were measured at different time-points
of tumor formation. Genes with differentiated expression
patterns are expected to play a role in the development of
human epidermal tumor development as well.
Preprocessed results where loaded into the FACT system
as text files containing the murine clone identifier and
expression values. Using mainly information from the
Ensembl database, FACT annotation functions acquired
corresponding gene names, genomic localizations, func-
tional information from Gene Ontology, homologues
human gene names and the genomic localization of those
genes (supplement S1, complete set of annotated data).
We applied different FACT analysis functions to explore
the expression data (for example the TermFinder function
to search for enriched functional groups of genes, figure
5). The function SimpleCount was used to search for
enriched functional categories of annotations. Using the
information of homologues genes, we were able to iden-
tify the human chromosomal band 1q21, as a region of
accumulated differentially expresses genes in murine skin
cancer formation (figure 4). The visual representation of
the loci using the ChromPlot function highlights these
findings (figure 6). With the MedLiner module we were to
confirm that several regulated genes were collectively
mentioned in previous publications (figure 7). A number
of genes (S100A3, S100A6, S100A8, S100A9) which are
part of the S100 family of calcium-binding proteins are
involved in the regulation of AP-1 and NFκB-dependent
transcription. Using FACT we were able to focus our anal-
ysis and to gain understanding of the relevance of the
results from the microarray study. With the application, it
was possible to find human homologues of the murine
tumor-associated genes and to confirm the involvement
of the S100 protein family in human epidermal
malignancies.
Table 2: Current data analysis and display modules
Method Name Reference Method Description
Simple Count FACT Count and display of occurrences of annotation 
terms
GO-Term Comparison In part from GO::TermFinder [15] Detection of significantly overrepresented GO 
terms in Gene List, based upon hypergeometric 
tail probability
MedLiner Bio::Biblio (M. Senger, EBI) List Publications with co-occurrences of terms
CGH database Deutsches Krebsforschungs-zentrum, Div. 
Molecular Genetics (D)
Compare CGH results to archived data
goCluster goCluster, G. Wrobel, available at http://
www.bioconductor.org
Detection of significantly overrepresented GO 
terms (based upon Fisher's exact test) in 
Clusters built with k-means algorithm
Hypergeometric Tail In part from GeneMerge [14] Detection of significantly overrepresented 
terms of any kind, based upon hypergeometric 
tail probability
CGH – Expression Comparison FACT Detect correlation between genomic and 
expression data sets, based on two-sided T-
Tests
Chromosomal Plot FACT Display values or occurrences in genomic 
contextPage 7 of 12
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There are several large-scale database projects that incor-
porate an immense spectrum of information about genes
and gene product (Ensembl, euGene, LocusLink/EntrezGene,
etc.). The Ensembl project for example also allows the user
to display his own selected data sources in the context of
the full genome annotation through the Distributed
Annotation System [19], and it offers the possibility of min-
ing the data of several genomes using the EnsMart soft-
ware [20]. FACT uses Ensembl, LocusLink/EntrezGene and
euGene data and complements them with other annota-
tion resources; it allows the user to apply different analysis
functions on the combined data.
Recently, a variety of computational tools have been
introduced to aid in the interpretation of results, some of
which are of interest concerning FACT. The majority of the
programs use GO annotations to gain an interpretation of
gene expression data. OntoExpress [13] was introduced in
2002 and offers the options to use hypergeometric, chi-
square, binomial and Fischer's exact test to score annota-
tion term derived from gene lists. It also allows the appli-
ance of different methods (False Discovery Rate (FDR),
Bonferroni, Holm, Sidak) for the multiple experiment
correction [17]. The program can also include KEGG path-
way information and chromosomal localization and is
now part of the Onto-Tools collection to offer further
Application of the FACT system for the functional analysis of microarray data of the development of non-melanoma skin can-cer (SimpleC unt function)Figure 4
Application of the FACT system for the functional analysis of microarray data of the development of non-
melanoma skin cancer (SimpleCount function). Occurrences of annotation terms are counted and displayed to draw the 
researchers attention to potentially characteristic features of the data set. In this case the genomic bands at 1q21 seem to play 
an important role in the experiment.Page 8 of 12
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variety of annotation options in their latest version
including all major database identifiers, protein domain
and pathway information. The Fisher's exact test is used
for the detection of enriched terms. GoMiner [23] and
numerous other tools listed at the GO website [24] can be
used for the annotation of gene lists with GO terms. Gen-
eMerge [14] uses the hypergeometric tail probability with
Bonferroni correction to test GO terms, genomic localiza-
tions and KEGG pathway information and is used in parts
within the FACT system. FACT uses the available Perl code
of GO::TermFinder [15] for the GO annotation and the
detection of significantly overrepresented terms using the
FDR. It also includes a function combining K-means clus-
tering and Fisher's exact test. GEPAS [25] and GECKO [26]
are two recently introduced large software packages that
include functional analysis and visualization steps. In
contrast to FACT they are focused on the initial statistical
evaluation and on the analysis of gene expression micro-
array data. GFINDer [27] is a system that offers annota-
tions on GO, pathway information, protein domains and
genetic disorders. It analyses with count functions and
appropriate tests (Hypergeometric, Binomial, Fisher's, Z
or Poisson Test).
This list of available tools is far from complete and not all
aspects are covered. The FACT system was developed with
the focus to include and extend the functionality of tools
like these. To our knowledge, the individual programs do
not offer the same degree of flexibility and openness to
different data sources and analysis methods. New func-
tions can be added to FACT by simply uploading the
respective module. The system is designed as an open
framework for the explorative analysis using a variety of
methods on annotational data. It is not restricted to or
focused on Gene Ontology-based interpretation or the
analysis of gene expression data alone and should facili-
tate the development and application of new analysis
approaches. The system is constantly being extended to
include additional aspects. With the submission as an
open-source project we want to encourage other research-
ers to participate in this development.
Application of the FACT system in non-melanoma skin cancer research (GoTerm function)Figure 5
Application of the FACT system in non-melanoma skin cancer research (GoTerm function). Overrepresented 
terms from a Gene Ontology annotation are displayed in a chart. The usage of the GO system is the most common approach 
for the functional interpretation of gene lists.Page 9 of 12
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To gain a more complete picture of results obtained from
high-throughput experiments such as DNA-microarrays,
automated procedures are required for annotation and
analysis. At the same time it is usually a matter of testing
and not known beforehand, which of the possible
approaches for the functional analysis will be the most
informative or appropriate. The Flexible Annotation and
Correlation Tool offers the flexibility to integrate and com-
pare annotation data and different algorithms in one
environment by using a unified data basis. Data sets of
different nature and format can be incorporated, diverse
analytical algorithms can be applied and the user can add
his own data integration and analysis functions. As a flex-
ible framework for the explorative meta-analysis of
genomic, proteomic or other experiments, FACT can help
with the task of analyzing the biological complexity,
allowing researchers to bridge gaps between different
kinds of experiments and acquiring a more complete
interpretation of large-scale experiments.
Availability and requirements
- Project name: Flexible Annotation and Correlation Tool
(FACT).
- Project home page: http://www.factweb.de
- Operating system: tested on Linux SUSE 9.1
- Programming language: Perl (5.8.1)
Application of the FACT system in non-melanoma skin cancer research (ChromPlot function)Figure 6
Application of the FACT system in non-melanoma skin cancer research (ChromPlot function). Visual representa-
tion of the genomic distribution of analyzed features highlights the involvement of the genomic band 1q21 (first 5 chromo-
somes shown). In this case the localization of human homologues genes corresponding to murine clones over- and under 
expressed in squamous cell carcinoma are displayed.Page 10 of 12
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cific modules: R (1.8.0 with RSPerl) and Bioconductor
(1.4.0); for full installation: Apache web-server (apache2-
prefork-2.0.48); additional Perl modules: BioPerl (1.2.1),
Ensembl (currently 28). Please refer to website for full
listing.
- License: Open Source GNU GPL (see licence document)
- Any restrictions to use by non-academics: written
licence needed
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